By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

JW Pharmaceutical Corporation (001065.KS)

KSC Currency in KRW
₩28.00K
-₩500.00
-1.75%
Last Update: 10 Sept 2025, 06:30
₩493.96B
Market Cap
10.60
P/E Ratio (TTM)
1.70%
Forward Dividend Yield
₩25.05K - ₩31.70K
52 Week Range

001065.KS Stock Price Chart

Explore JW Pharmaceutical Corporation interactive price chart. Choose custom timeframes to analyze 001065.KS price movements and trends.

001065.KS Company Profile

Discover essential business fundamentals and corporate details for JW Pharmaceutical Corporation (001065.KS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

29 Sept 2005

Employees

1.06K

CEO

Young-Sub Shin

Description

JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.

001065.KS Financial Timeline

Browse a chronological timeline of JW Pharmaceutical Corporation corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 5 May 2026

Upcoming earnings on 5 Feb 2026

Upcoming earnings on 4 Nov 2025

Earnings released on 31 Jul 2025

Revenue for the quarter reached ₩192.25B , meeting expectations.

Earnings released on 15 May 2025

EPS came in at ₩752.88 , while revenue for the quarter reached ₩185.24B , beating expectations by +1.11%.

Earnings released on 7 Feb 2025

EPS came in at ₩712.00 , while revenue for the quarter reached ₩187.85B , missing expectations by -1.08%.

Dividend declared on 27 Dec 2024

A dividend of ₩475.00 per share was announced, adjusted to ₩475.00. The dividend was paid on 25 Apr 2025.

Earnings released on 7 Nov 2024

EPS came in at ₩844.22 , while revenue for the quarter reached ₩178.66B , missing expectations by -4.28%.

Earnings released on 1 Aug 2024

EPS came in at ₩364.90 , while revenue for the quarter reached ₩172.28B , missing expectations by -9.76%.

Earnings released on 8 May 2024

EPS came in at ₩860.12 , while revenue for the quarter reached ₩180.59B , missing expectations by -4.94%.

Earnings released on 27 Mar 2024

EPS came in at ₩1.09K , while revenue for the quarter reached ₩205.02B , missing expectations by -0.81%.

Dividend declared on 27 Dec 2023

A dividend of ₩425.00 per share was announced, adjusted to ₩425.00. The dividend was paid on 26 Apr 2024.

Stock split effective on 27 Dec 2023

Shares were split 51 : 50 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Sept 2023

EPS came in at -₩767.96 , while revenue for the quarter reached ₩184.20B , missing expectations by -2.77%.

Earnings released on 30 Jun 2023

EPS came in at ₩618.24 , while revenue for the quarter reached ₩185.92B , missing expectations by -0.13%.

Earnings released on 31 Mar 2023

EPS came in at ₩665.07 , while revenue for the quarter reached ₩173.38B , missing expectations by -1.54%.

Stock split effective on 13 Mar 2023

Shares were split 103 : 100 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Dec 2022

EPS came in at ₩558.33 , while revenue for the quarter reached ₩193.16B , beating expectations by +4.63%.

Dividend declared on 28 Dec 2022

A dividend of ₩400.00 per share was announced, adjusted to ₩380.73. The dividend was paid on 28 Apr 2023.

Earnings released on 30 Sept 2022

EPS came in at ₩77.05 , while revenue for the quarter reached ₩169.85B , beating expectations by +1.63%.

Earnings released on 30 Jun 2022

EPS came in at ₩9.13 , while revenue for the quarter reached ₩165.00B , beating expectations by +1.11%.

Earnings released on 31 Mar 2022

EPS came in at ₩89.06 , while revenue for the quarter reached ₩156.34B , missing expectations by -0.23%.

Earnings released on 31 Dec 2021

EPS came in at -₩62.51 , while revenue for the quarter reached ₩169.47B .

Dividend declared on 29 Dec 2021

A dividend of ₩350.00 per share was announced, adjusted to ₩333.14. The dividend was paid on 29 Apr 2022.

Stock split effective on 29 Dec 2021

Shares were split 103 : 100 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Sept 2021

EPS came in at ₩209.32 , while revenue for the quarter reached ₩148.99B .

Earnings released on 30 Jun 2021

EPS came in at -₩138.32 , while revenue for the quarter reached ₩146.03B .

Earnings released on 31 Mar 2021

EPS came in at ₩165.80 , while revenue for the quarter reached ₩142.09B .

Earnings released on 31 Dec 2020

EPS came in at -₩285.75 , while revenue for the quarter reached ₩144.71B .

Dividend declared on 29 Dec 2020

A dividend of ₩339.81 per share was announced, adjusted to ₩314.02. The dividend was paid on 23 Apr 2021.

Stock split effective on 29 Dec 2020

Shares were split 103 : 100 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Sept 2020

EPS came in at ₩121.36 , while revenue for the quarter reached ₩137.14B .

001065.KS Stock Performance

Access detailed 001065.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run